Institute of Molecular Medicine, RWTH Aachen University, Aachen, Germany.
Institute of Medical Microbiology, RWTH Aachen University, Aachen, Germany.
Nat Rev Gastroenterol Hepatol. 2023 Jul;20(7):447-461. doi: 10.1038/s41575-023-00771-6. Epub 2023 Apr 21.
The gut and the liver are characterized by mutual interactions between both organs, the microbiome, diet and other environmental factors. The sum of these interactions is conceptualized as the gut-liver axis. In this Review we discuss the gut-liver axis, concentrating on the barriers formed by the enterohepatic tissues to restrict gut-derived microorganisms, microbial stimuli and dietary constituents. In addition, we discuss the establishment of barriers in the gut and liver during development and their cooperative function in the adult host. We detail the interplay between microbial and dietary metabolites, the intestinal epithelium, vascular endothelium, the immune system and the various host soluble factors, and how this interplay establishes a homeostatic balance in the healthy gut and liver. Finally, we highlight how this balance is disrupted in diseases of the gut and liver, outline the existing therapeutics and describe the cutting-edge discoveries that could lead to the development of novel treatment approaches.
肠道和肝脏的特点是两者之间的相互作用、微生物组、饮食和其他环境因素。这些相互作用的总和被概念化为肠-肝轴。在这篇综述中,我们讨论了肠-肝轴,重点讨论了由肠肝组织形成的屏障,以限制肠道来源的微生物、微生物刺激物和饮食成分。此外,我们还讨论了在发育过程中肠道和肝脏屏障的建立及其在成年宿主中的合作功能。我们详细介绍了微生物和饮食代谢物、肠上皮、血管内皮、免疫系统和各种宿主可溶性因子之间的相互作用,以及这种相互作用如何在健康的肠道和肝脏中建立一个平衡状态。最后,我们强调了这种平衡在肠道和肝脏疾病中是如何被打破的,概述了现有的治疗方法,并描述了可能导致新的治疗方法发展的前沿发现。